Evidence map›Paper›PMID 28074070›Full record

ArticleLeukemia2017

Gain of function in Jak2

G Nishanth, D Wolleschak, C Fahldieck, T Fischer, A Mullally, F Perner, T M Schnöder, S Just, F H Heidel, D Schlüter

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

G NishanthInstitute for Medical Microbiology and Hospital Hygiene, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
D WolleschakDepartment of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
C FahldieckDepartment of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
T FischerDepartment of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
A MullallyDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
F PernerDepartment of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
T M SchnöderInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.
S JustInstitute for Medical Microbiology and Hospital Hygiene, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
F H HeidelInnere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.
D SchlüterInstitute for Medical Microbiology and Hospital Hygiene, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCD3 ComplexCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesGranulocytesHematopoietic Stem CellsHumansJanus Kinase 2MiceMice, Inbred C57BLMutationMyeloproliferative DisordersCD3 ComplexJanus Kinase 2

Identifiers

PMID28074070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.